In vitro comparison of the effect of two factor XI (FXI) concentrates on thrombin generation in major FXI deficiency

@article{Pike2016InVC,
  title={In vitro comparison of the effect of two factor XI (FXI) concentrates on thrombin generation in major FXI deficiency},
  author={G. Pike and A. Cumming and C. Hay and B. Sempasa and M. Sutherland and J. Thachil and J. Burthem and P. Bolton-Maggs},
  journal={Haemophilia},
  year={2016},
  volume={22}
}
  • G. Pike, A. Cumming, +5 authors P. Bolton-Maggs
  • Published 2016
  • Medicine
  • Haemophilia
  • Bleeding risk in factor XI (FXI) deficiency following surgery may be reduced by treatment with either of two FXI concentrates, but indications for their use are unclear and treatment has been associated with thrombosis. 
    8 Citations
    Evaluation of the use of global haemostasis assays to monitor treatment in factor XI deficiency
    • 9
    Genomic Sequencing for Newborn Screening: Results of the NC NEXUS Project.

    References

    SHOWING 1-10 OF 34 REFERENCES
    Factor XI‐related thrombosis and the role of concentrate treatment in factor XI deficiency
    • 15
    Clinical experience of factor XI deficiency: the role of fresh frozen plasma and factor XI concentrate
    • 38
    Ongoing risk of thrombosis with factor XI concentrate: 5 years experience in two centres
    • 23
    Thrombin generation in patients with factor XI deficiency and clinical bleeding risk
    • 62
    Factor XI deficiency and its management
    • J. K. Smith
    • Medicine
    • Haemophilia : the official journal of the World Federation of Hemophilia
    • 1996
    • 29